Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Simplifying changes requires clear steps and reminders. Learn practical ways to make mid-month edits that stick and save you time.
23,940 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
The SEC has approved a slate of spot XRP ETFs, opening direct XRP exposure for retail and institutional investors wit...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
Investor nerves rose as here's gemini space station faced a sharp price drop this week. This piece breaks down what s...
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
Medicare is tightening oversight on hospice providers amid rising admissions and fraud concerns. The crackdown could ...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
FuboTV’s reverse split failed to spark a lasting rally, with shares sliding as the company reports rising revenue but...
A joint Accenture-Wharton study finds AI agents can scale thinking, but human governance struggles to keep pace, crea...
A major security misconfiguration at Anthropic left internal assets, including notes on an unreleased model and CEO r...